Background
==========

Rapidly growing mycobacteria (RGM) infections in immunocompetent persons, as well as in persons with predisposing factors or who are immunosuppressed, are being reported more frequently \[[@B1],[@B2]\]. Particularly, of the RGMs, *Mycobacterium abscessus* − complex is commonly associated with wound infections and abscess formation and is the most frequent RGM causing chronic lung disease \[[@B3],[@B4]\]. Recent application of the combinatorial taxonomy including biochemical tests, anti-microbial susceptibility test, and multi-locus sequencing approach have suggested that the *M. abscessus* − complex is actually subdivided into three species: *Mycobacterium abscessus* subsp. *abscessus, M abscessus* subsp. *massiliense,* and *M. abscessus* subsp. *bolletii*; which exhibit clinically relevant differences in their antibiotic sensitivity profiles \[[@B5]-[@B7]\]. In South Korea, infection by members of the *M. abscessus* − complex is the most prevalent of RGM infections and second to the *M. avium* − complex of non-tuberculous mycobacteria (NTM) \[[@B8]\].

NTM has long been known to have both rough and smooth colony phenotypes \[[@B9],[@B10]\]. This may be due mainly to the expression levels of glycopeptidolipids (GPLs). GPLs are produced by several NTMs, including RGMs, such as *M. abscessus*, *M. chelonae* and *M. smegmatis*, \[[@B11]-[@B13]\] and *M. avium* − complex (MAC) members, such as *M. avium* and *M. intracellulare*\[[@B14]-[@B16]\]. GPLs are responsible for smooth colonies and contribute to colonization of NTMs in the environment via biofilm formation; while, loss of GPLs is correlated with rough colonies and facilitates survival in macrophages \[[@B17]\].

In the *M. abscessus* − complex strains, smooth phenotypes have occasionally spontaneously reverted to rough morphotypes after several passages on agar plates or via in vivo passage into mice \[[@B17]\]. It was reported that there is a positive correlation between colony morphology and virulence, with rough variants generally being more virulent than smooth variants \[[@B17],[@B18]\]. This may be due primarily to the reduced expression of GPL, resulting in excessive secretion of TNF-α by the macrophage \[[@B18]\]. Recently, targeted deletion of a gene, *mmpL4b*, in the *M. abscessus* is also reported to lead to loss of GPL and to show enhanced invasive abilities \[[@B19]\].

A recent molecular epidemiology study based on partial *hsp65* sequences (603 bp) indicated that *M. massiliense* (65/109 patients, 59.6%) of *M. abscessus* complex strains was more prevalent than *M. abscessus* (44/109 patients, 40.4%) in South Korea \[[@B20]\]. Interestingly, infections in 30 of 65 Korean patients (46.2%) with *M. massiliense*, were found to be caused by a distinct Type II genotype not encountered in other areas \[[@B20]\].

The most characteristic feature of this novel genotype is that all its strains showed the rough colony morphotype. This suggests that its rough colony phenotype may be due to an irreversible genetic factor rather than the reversible spontaneous reversion from smooth to rough morphotype previously introduced as a major mechanism for acquisition of the rough phenotype in *M. abscessus* − complex strains \[[@B17]\].

The aim of this study was to prove our hypothesis that the rough colony phenotype of the new *M. massiliense* Type II genotype may be genetically determined. For this purpose, we first compared the GPL biosynthesis related gene loci of *M. massiliense* Asan 50594, belonging to the Type II genotype for which we recently provided a complete genome, with those of other RGMs \[[@B21]\]. Second, to check whether GPL deletion is distinct for *M. massiliense* Type II genotype of *M. abscessus* − complex strains, PCR assays for the detection of GPL deletions were applied to the *M. abscessus* complex clinical strains, including a variety of groups.

Results
=======

Differences between GPL expression patterns of *M. massiliense* Type I and Type II strains
------------------------------------------------------------------------------------------

To check out the differences in the GPL expression patterns of *M. massiliense* Type I and Type II strains, purified GPLs were examined and analyzed using matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). Pronounced differences in the MALDI-TOF MS profiles were found between the GPLs of the two genotypes. In the case of *M. massiliense* Type I strain Asan 51843, the MALDI-TOF MS profiles showed two distinct clusters of peaks ranging from *m/z* 1101 to *m/z* 1245 and from *m/z* 1287 to *m/z* 1419, corresponding to diglycosylated GPL and triglycosylated GPL, respectively (Figure [1](#F1){ref-type="fig"}A). All four of the other Type I strains also showed MALDI-TOF mass spectrometry profiles similar to Strain 51843 (Additional file [1](#S1){ref-type="supplementary-material"}). However, the MALDI-TOF MS profiles of GPLs from *M. massiliense* Type II Asan 50594, were showed unusual, with significantly lower intensity of the peaks corresponding to the putative GPLs, compared to the profiles of the Type I strains (Figure [1](#F1){ref-type="fig"}B). Also, all four of the other Type II strains showed MALDI-TOF MS profiles similar to Strain 50594 (Additional file [1](#S1){ref-type="supplementary-material"}). This means that there was loss of GPLs in the cell wall components of the *M. massiliense* Type II strains.

![**MALDI-TOF MS analysis of extracted GPLs from: (A)*M. massiliense*Type I Asan 51843, (B)*M. massiliense*Type II Asan 50594.** Abbreviations: DG, diglycosylated GPLs; TG, triglycosylated GPLs; PIM2, phosphatidylinositol dimannoside.](1471-2164-14-890-1){#F1}

Comparative genomic analysis of the GPL biosynthesis related locus
------------------------------------------------------------------

To check out whether the GPL loss in *M. massiliense* Type II is genetically determined or not, we performed comparative genomic analysis of 29 GPL biosynthesis related genes (one larger cluster of \~40 kbp covering 19 genes, one smaller cluster of \~19 kbp covering 6 genes and four distributed genes in *M. abscessus*) from *M. massiliense* Type II Asan 50594 (GenBank Accession No., CP004374) and four other RGMs, \[*M. abscessus* CIP 104536^T^ (GenBank Accession No., NC_010397), *M. massiliense* CCUG 48898^T^ (GenBank Accession No., AKVF00000000), *M. chelonae* CIP 104535^T^ (GenBank Accession No., AM231610-AM231615), and *M. smegmatis* str MC^2^ 155 (GenBank Accession No., AY439015)\] \[[@B13],[@B21],[@B22]\].

When compared with *M. abscessus* CIP 104536^T^ and *M. massiliense* CCUG 48898^T^, or *M. massiliense* Type II Asan 50594, the percentage of identity of amino acids between 2 strains ranges between 86 and 100% (Table [1](#T1){ref-type="table"}). Similar to the *M. abscessus* CIP 104536^T^, *M. massiliense* CCUG 48898^T^ or *M. massiliense* Type II Asan 50594 have GPL biosynthesis related genes which were divided into two clusters. In the genome of *M. massiliense* Type II Asan 50594, one cluster of \~11 kbp covering 8 genes (from MASS_4108 to MASS_4116, counterparts for *gap* to *mmpS4* in *M. abscessus*), one cluster of \~19 kbp covering 6 genes (from MASS_0918 to MASS_0923, counterparts for *gap*-like to *pks* in *M. abscessus*) and five distributed genes (MASS_4474, 4488, 4493, 4660 and 4722, counterparts for *fadE5*, *sap*, *ecf*, *Rv0926* and *mbtH* in *M. abscessus*, respectively) were found among the GPL-biosynthesis related genes. Interestingly, compared to other RGMs, there are no counterparts of 10 GPL biosynthesis related genes in the genome of *M. massiliense* Type II Asan 50594 (Table [1](#T1){ref-type="table"}, Figure [2](#F2){ref-type="fig"}). All the deleted genes were found in the region corresponding to the first larger GPL cluster in *M. abscessus* CIP 104536^T^ or *M. massiliense* CCUG 48898^T^. Genes *atf1* and *atf2*, which are responsible for acetylation \[[@B23]\]; *gtf1* and *gtf2*, which are involved in the glycosylation of the lipopeptide core \[[@B24],[@B25]\]; *rmt2*, *rmt3*, and *rmt4*, which are involved in the *O*-methylation of the various hydroxyl groups of the rhamnosyl unit; *fmt*, which is also involved in the *O*-methylation of the lipid moiety \[[@B26]-[@B28]\]; and *mps1* and *mps2*, which are responsible for assembling the tripeptide-aminoalcohol moiety \[[@B29]\], were deleted from the GPL locus of *M. massiliense* Type II Asan 50594 (Table [1](#T1){ref-type="table"}, Figure [2](#F2){ref-type="fig"} and Figure [3](#F3){ref-type="fig"}).

###### 

**GPL biosynthesis related genes of*M. abscessus***, ***M. massiliense***, ***M. massiliense*** type II, ***M. chelonae*** and ***M. smegmatis***

   ***M. abscessus***^**a**^   ***M. massiliense***^**b**^                 ***M. massiliense*Type II**^**c**^                  ***M. chelonae***^**d**^   ***M. smegmatis***^**e**^                                                
  --------------------------- ----------------------------- ----------------------------------------------------------------- -------------------------- --------------------------- ----------- ----- --------- ----- ----------- ----
             mmpS4                      MAB_4117c                        Putative membrane protein, MmpS family                       MMAS_40600                     100              MASS_4116   100   MC1618    95    MSMEG0373   78
            mmpL4a                      MAB_4116c                            Putative membrane protein, MmpL                          MMAS_40590                     100              MASS_4115   100   MC1619    95    MSMEG0374   78
            mmpL4b                      MAB_4115c                            Putative membrane protein, MmpL                          MMAS_40580                     99               MASS_4114   99    MC1620    92    MSMEG0375   76
            Rv1174                      MAB_4114c                            Conserved hypothetical protein                           MMAS_40570                     99               MASS_4113   99    MC1621c   89    MSMEG0376   48
             rmlA                       MAB_4113                        Glucose-1-phosphate thymidylyltransferase                     MMAS_40560                     100              MASS_4112   100   MC1622c   97    MSMEG0377   85
             gtf3                       MAB_4112c                           Putative glycosyltransferase GtfA                         MMAS_40540                     98               MASS_4110   99    MC1623    88    MSMEG0378   70
             rmlB                       MAB_4111c                            Putative epimerase/dehydratase                           MMAS_40530                     99               MASS_4109   99    MC1624    93    MSMEG0379   78
             atf2                       MAB_4110c                            Probable acetyltransferase AtfA                          MMAS_40520                     97                                 MC1625    89                 
             rmt2                       MAB_4109c                              Putative methyltransferase                             MMAS_40510                     98                                 MC1626    82    MSMEG0380   72
             rmt4                       MAB_4108c                                Methyltransferase MtfB                               MMAS_40500                     99                                 MC1627    96    MSMEG0381   83
             gtf1                       MAB_4107c                               Glycosyltransferase GtfA                              MMAS_40490                     99                                 MC1628    92    MSMEG0382   76
             atf1                       MAB_4106c                                   Acetyltransferase                                 MMAS_40480                     98                                 MC1629    89    MSMEG0383   72
             rmt3                       MAB_4105c                                Methyltransferase MtfD                               MMAS_40470                     100                                MC1630    92    MSMEG0384   81
             gtf2                       MAB_4104c                           Putative glycosyltransferase GtfB                         MMAS_40460                     97                                 MC1631c   81    MSMEG0385   67
              fmt                       MAB_4103c                              Probable methyltransferase                             MMAS_40450                     99                                 MC1632    85    MSMEG0386   68
             mbtH                       MAB_4100c                                   MbtH-like protein                                 MMAS_40430                     99               MASS_4722   86    MC1635    100   MSMEG0387   91
             mps1                       MAB_4099c                       Probable non-ribosomal peptide synthetase                     MMAS_40410                     99                                 MC1636    86    MSMEG0390   70
             mps2                       MAB_4098c                            Probable peptide synthetase NRP                          MMAS_40400                     99                                 MC1637    91    MSMEG0392   72
              gap                       MAB_4097c                            Conserved hypothetical protein                           MMAS_40390                     99               MASS_4108   99    MC1638    85    MSMEG0393   58
              sap                       MAB_4454c                     Conserved hypothetical protein (DGPF family)                    MMAS_43620                     99               MASS_4488   98    MC1299    94    MSMEG0394   31
              ecf                       MAB_4459c                     RNA polymerase sigma-70 factor, ECF subfamily                   MMAS_43670                     98               MASS_4493   96    MC1294    85    MSMEG0395   47
             fadE5                      MAB_4437                          Probable acyl-CoA dehydrogenase FadE                        MMAS_43460                     99               MASS_4474   99    MC1318c   96    MSMEG0396   78
            Rv0926                      MAB_4633                             Conserved hypothetical protein                           MMAS_45360                     99               MASS_4660   99    MC1136c   91    MSMEG0397   36
              pks                       MAB_0939                              Probable polyketide synthase                            MMAS_07820                     99               MASS_0923   98    MC0819    90    MSMEG0398   79
             papA3                      MAB_0938c            Probable conserved polyketide synthase associated protein PapA3          MMAS_07800                     99               MASS_0922   99    MC0818c   92    MSMEG0399   78
            mmpL10                      MAB_0937c                        Putative membrane protein, MmpL family                       MMAS_07790                     99               MASS_0921   99    MC0817c   95    MSMEG0400   75
              PE                        MAB_0936c                            Conserved hypothetical protein                           MMAS_07780                     99               MASS_0920   99    MC0816c   89    MSMEG0402   64
            fadD23                      MAB_0935c                                  acyl-CoA synthetase                                MMAS_07770                     99               MASS_0919   99    MC0815c   88    MSMEG0401   73
           gap-like                     MAB_0934                    Conserved hypothetical integral membrane protein                  MMAS_07760                     98               MASS_0918   98    MC0814    88    MSMEG0403   54

^*a*^Accession number: NC_010397 (13).

^*b*^Accession number: AKVF00000000 (24).

^*c*^Accession number: CP004374 (20).

^*d*^Accession number: AM231610-AM231615 (13).

^*e*^Accession number: AY439015 (13).

![**Organization of GPL biosynthesis related genes.** Color code: Light blue -- mmpL family; black -- unknown; purple -- sugar biosynthesis, activation, transfer and modifications; red -- lipid biosynthesis, activation, transfer and modifications; green -- pseudopeptide biosynthesis; yellow -- required for GPL transport to the surface; grey -- regulation.](1471-2164-14-890-2){#F2}

![**Schematic representation of the structure of the GPLs from*M. smegmatis*(13).** The genes involved in GPL synthesis are indicated in brackets and the genes deleted in *M. massiliense* Type II Asan 50594, are indicated with strikethrough line. Abbreviations: OAc, acetyl; OMe, methyl; dTal, 6-deoxytalose; D-Rha, rhamnose of the D series.](1471-2164-14-890-3){#F3}

Considering that GPLs are related to formation of smooth colonies, these deletions represent the phenotypic characteristics of *M. massiliense* Type II, which only occurred in rough colonies \[[@B20]\].

PCR confirmation of GPL biosynthesis related genes from *M. massiliense* and *M. abscessus* clinical isolates
-------------------------------------------------------------------------------------------------------------

To check the presence of the GPL biosynthesis related genes from *M. massiliense* and *M. abscessus* clinical isolates, DNAs from 76 *M. abscessus* related strains were amplified by PCRs using 12 primer sets (Additional file [2](#S2){ref-type="supplementary-material"}), which targets 10 deleted genes in Asan 50594 genome: *atf1*, *atf2*, *fmt*, *gtf1*, *gtf2*, *rmt2*, *rmt3*, *rmt4*, *mps1*, and *mps2* and 2 conserved genes as PCR positive controls: *gap* and *rmlB* genes, which were found in the genome of all *M. abscessus* related strains including Asan 50594. Of 76 strains, 21 strains of *M. massiliense* Type II were not amplified by PCRs targeting 10 deleted genes in Asan 50594 genome, but amplified by PCRs targeting 2 conserved genes, suggesting the loss of corresponding GPL genes in all 21 *M. massiliense* Type II strains. But, all the remaining 55 strains were positively amplified by PCRs targeting 10 deleted genes as well as 2 conserved genes, suggesting the presence of targeted GPL biosynthesis genes in their genome. It should be noted that all the 23 strains with rough colony morphotype (12 *M. massiliense* Type I and 11 *M. abscessus* strains) except for *M. massiliense* Type II produced positive amplifications in PCRs targeting 10 deleted genes, suggesting there may be the disparity between *M. massiliense* Type II and other related strains in mechanism leading to rough colony phenotype (Figure [4](#F4){ref-type="fig"}, Table [2](#T2){ref-type="table"} and Additional file [3](#S3){ref-type="supplementary-material"}).

![**Confirmation of deleted GPL biosynthesis related genes by PCR among clinically isolated*M. massiliense*and*M. abscessus.*** M, 100 bp DNA ladder; Lane 1, *M. massiliense* Type I Asan 51843; Lane 2, *M. massiliense* Type I Asan 50375; Lane 3, *M. massiliense* Type I Asan 15; Lane 4, *M. massiliense* Type II Asan 50594; Lane 5, *M. massiliense* Type II Asan 52012; Lane 6, *M. massiliense* Type II Asan 1; Lane 7, *M. massiliense* Type I (rough) Asan 22; Lane 8, *M. massiliense* Type I (rough) Asan 23; Lane 9, *M. massiliense* Type I (rough) Asan 54790; Lane 10, *M. abscessus* (smooth) Asan 57214; Lane 11, *M. abscessus* (smooth) Asan 57388; Lane 12, *M. abscessus* (smooth) Asan 58417; Lane 13, *M. abscessus* (rough) Asan 55088; Lane 14, *M. abscessus* (rough) Asan 56232; Lane 15, *M. abscessus* (rough) Asan 56544; N, negative control.](1471-2164-14-890-4){#F4}

###### 

PCR results of deleted or conserved genes at the GPL biosynthesis related locus from ***M. massiliense*** Type I, ***M. massiliense*** Type II, ***M. massiliense*** Type I (rough colony morphology), and ***M. abscessus*** (smooth and rough colony morphology), strains

                                                                    **PCR results \[No. (%)\]**                                            
  -------------------------------------------------- ------------- ----------------------------- ------------- ------------- ------------- -------------
   Deleted genes in *M. massiliense* Type II strain     *atf1*              21/21 (100)            0/21 (0)     12/12 (100)   11/11 (100)   11/11 (100)
                        *atf2*                        21/21 (100)            0/21 (0)             12/12 (100)   11/11 (100)   11/11 (100)  
                        *fmt*                         21/21 (100)            0/21 (0)             12/12 (100)   11/11 (100)   11/11 (100)  
                        *gtf1*                        21/21 (100)            0/21 (0)             12/12 (100)   11/11 (100)   11/11 (100)  
                        *gtf2*                        21/21 (100)            0/21 (0)             12/12 (100)   11/11 (100)   11/11 (100)  
                        *mps1*                        21/21 (100)            0/21 (0)             12/12 (100)   11/11 (100)   11/11 (100)  
                        *mps2*                        21/21 (100)            0/21 (0)             12/12 (100)   11/11 (100)   11/11 (100)  
                        *rmt2*                        21/21 (100)            0/21 (0)             12/12 (100)   11/11 (100)   11/11 (100)  
                        *rmt3*                        21/21 (100)            0/21 (0)             12/12 (100)   11/11 (100)   11/11 (100)  
                        *rmt4*                        21/21 (100)            0/21 (0)             12/12 (100)   11/11 (100)   11/11 (100)  
                   Conserved genes                       *gap*              21/21 (100)           21/21 (100)   12/12 (100)   11/11 (100)   11/11 (100)
                                                        *rmlB*              21/21 (100)           21/21 (100)   12/12 (100)   11/11 (100)   11/11 (100)

Discussion
==========

Infection by *M. massiliense* strains of RGMs has gained importance together with its increasing prevalence over the world \[[@B30]-[@B35]\]. In particular, a recent study based on whole genome sequencing revealed the first evidence of human to human transmission in NTM infection, by proving its transmission between cystic fibrosis patients; suggesting unusually high infectivity of humans by *M. massiliense* strains \[[@B36]\]. In South Korea, a distinct epidemiologic trend was reported \[[@B37]\], of higher prevalence of *M. massiliense* strains (of the *M. abscessus* − complex); part of which may be attributed to the presence of the *M. massiliense* Type II genotype found only in Korean patients \[[@B20]\].

The combination of our genomic and molecular epidemiologic data in this study proved that all the strains belonging to a novel *M. massiliense* Type II genotype, showed loss of genes related to GPL biosynthesis (10 of 29 consecutive genes in *M. abscessus*) (Table [1](#T1){ref-type="table"}, Figure [2](#F2){ref-type="fig"} and Figure [3](#F3){ref-type="fig"}), resulting in irreversible rough phenotypes. Our PCR data targeting 12 GPL biosynthesis genes suggested that there may be the disparity between 2 groups, *M. massiliense* Type II and other *M. abscessus* related strains in evoking rough colony phenotypes. Unlike the former acquiring rough phenotype via a genetically determined mechanism, it cannot be excluded that GPL loss of the latter may be mediated by a not-yet determined non-genetic mechanism leading to the transient GPL loss, as reported in other papers \[[@B17]\]. But, the exact mechanism related to rough colony phenotype of the latter has to be elucidated in the future.

To our knowledge, this is the first report regarding this genetic defect of GPL biosynthesis in NTMs. Unlike for the *M. tuberculosis* − complex strains capable of transmission from human to human, in general, NTMs can infect humans only from environmental sources, although infection between cystic fibrosis patients by *M. abscessus* − complex strains has recently been reported \[[@B36]\]. Therefore, GPL is generally necessary for NTM survival in the natural environment (soils and water), and for human infection from environmental sources \[[@B17],[@B23]\]. Particularly, in *M. abscessus* strains, the change of colony morphology from smooth to rough type, which provides an advantage for survival within a host macrophage, has so far been reported to happen spontaneously after host infection by reduction of GPL expression; not by irreversible genetic loss \[[@B17],[@B36]\].

Given that *M. tuberculosis* − complex strains are strict pathogens that do not harbor gene loci related to GPL biosynthesis within their genomes, it is inferred that strains belonging to the *M. massiliense* Type II genotype may be more adapted to human infection than other members of *M. abscessus* complex. After sub-cultures of more than 10 generations on 7H9 broth or 7H10 agar plates, the reversion of rough to smooth type was not found in any Type II strains (data not shown). This further supports our hypothesis that the rough morphotype of Type II, like *M. tuberculosis*, may be an innate (genetic) trait derived from a smooth strain by evolutionary events, rather than a transient trait acquired during an *in vivo* infection.

Collectively considering our data only for the selective separation of the *M. massiliense* Type II genotype, we recommended combinatorial PCRs targeting both GPL deletion and conserved genes (e.g., *hsp65*), because they can be used for simple separation of the genotypes without additional procedures such as sequencing or PCR restriction analysis.

Conclusions
===========

In conclusion, our data showed that the *M. massiliense* Type II genotype showed gene loss related to GPL biosynthesis within its genome, resulting in a rough colony phenotype. To our knowledge, this is the first report of an NTM with a rough colony phenotype genetically determined by GPL gene loss.

Methods
=======

Bacterial strains
-----------------

All clinically isolated *M. abscessus* and *M. massiliense*\[[@B20]\] used in this study were cultured in 7H9 broth supplemented with 10% ADC at 37°C for 3 days. For MALDI-TOF analysis, five *M. massiliense* Type I (50375, 51843, 52352, Asan 7 and Asan 15) and five *M. massiliense* Type II (50594, 51048, 52012, Asan 1 and Asan 19) strains were used. For the PCR confirmation of GPL biosynthesis-related genes, a total of 76 strains \[*M. massiliense* Type I (21 strains), *M. massiliense* Type II (21 strains), rough *M. massiliense* Type I (12 strains), smooth *M. abscessus* (11 strains) and rough *M. abscessus* (11 strains)\] were used and listed in Table [3](#T3){ref-type="table"} and Additional file [4](#S4){ref-type="supplementary-material"}. All clinical strains were selected from among the 109 strains used in the previous report \[[@B20]\]. Separation of all *M. abscessus* − complex strains into genotypes or subspecies was performed by 603-bp *hsp65* based sequence analysis as described previously \[[@B20]\].

###### 

**Clinically isolated*M. abscessus*** and ***M. massiliense*** used in this study

  ***M. massiliense***   
  ---------------------- ----
  Type I                 21
  Type II                21
  Type I (R)             12
  ***M. abscessus***     
  Smooth                 11
  Rough                  11
  Total                  76

Abbreviations: Type I, *M. massiliense* Type I strain; Type II, *M. massiliense* Type II strain; Type I (R), *M. massiliense* Type I (rough colony morphology) strain.

Glycopeptidolipid (GPL) extraction
----------------------------------

To characterize the GPL profiles of the *M. massiliense* Type I and Type II strains, five Type I (50375, 51843, 52352, Asan 7 and Asan 15) or Type II (50594, 51048, 52012, Asan 1 and Asan 19) strains were harvested at exponential phases of growth, and separated from the culture media by centrifugation at 4,000 rpm for 15 min. Each bacterial pellet was suspended in CHCl~3~/CH~3~OH \[2:1, v/v; 10 ml/g (wet weight of bacterial pellet)\]; sonicated two times (pulse for 1 min and stop for 10 sec, total 15 min), and incubated at 4°C overnight. After that, the suspensions were centrifuged to remove insoluble material and subjected to biphasic partitioning in CHCl~3~/CH~3~OH/H~2~O (4:2:1, v/v). Total lipid extracts were treated with an equal volume of NaOH (0.2 M in CH~3~OH, 45 min at 37°C), neutralized with glacial acetic acid, and dried in air. Finally, GPLs were extracted in CH~3~Cl/CH~3~OH (2:1, v/v) \[[@B17],[@B38],[@B39]\].

Matrix-Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF) mass spectrometry analysis
-------------------------------------------------------------------------------------------------

MALDI-TOF mass spectrometry was performed on the extracted GPLs with a Voyager DE-STR MALDI-TOF instrument (Perseptive Biosystems) equipped with a pulse nitrogen laser emitting at 337 nm as previously described \[[@B24],[@B40]\].

Genome analysis of GPL biosynthesis related gene loci comparing *M. massiliense* Asan 50594 and other RGMs
----------------------------------------------------------------------------------------------------------

The comparative genomic analysis was performed via comparison of pairwise alignments between the amino acid sequences of the GPL biosynthesis related 29 genes of *M. abscessus* CIP 104536^T^ (GenBank Accession No., NC_010397), *M. massiliense* CCUG 48898^T^ (GenBank Accession No., AKVF00000000), *M. massiliense* Type II Asan 50594 (GenBank Accession No., CP004374), *M. chelonae* CIP 104535^T^ (GenBank Accession No., AM231610-AM231615) and *M. smegmatis* str. MC^2^ 155 (GenBank Accession No., AY439015) \[[@B13],[@B21],[@B22]\]. The comparative genomic analysis was performed by pairwise alignments between the amino acid sequences of the GPL biosynthesis related genes of *M. massiliense* Type II Asan 50594 and the other RGMs mentioned above. Comparisons were performed using the MegAlign \[[@B41]\] and BLASTP program (<http://blast.ncbi.nlm.nih.gov/Blast.cgi>), and percentage of identities for genes were calculated.

PCR applications targeting 12 GPL biosynthesis related genes
------------------------------------------------------------

Total DNA was extracted from colonies using the bead beater-phenol extraction method, and then used as templates for PCR. To check the presence of GPL biosynthesis related genes in *M. abscessus* complex strains, we used purified DNAs from 76 clinical isolates, which included 33 *M. massiliense* Type I (21 strains: smooth, 12 strains:rough), 21 *M. massiliense* Type II (rough), and 22 *M. abscessus* (11 strains: smooth, 11 strains: rough) (Additional file [4](#S4){ref-type="supplementary-material"}). Using the *M. abscessus* CIP 104536^T^ (GenBank Accession No., NC_010397) and *M. massilense* CCUG 49989^T^ (GenBank Accession No., AKVF00000000) genome sequences \[[@B13],[@B22]\], 12 primer sets were designed (Additional file [2](#S2){ref-type="supplementary-material"}). To amplify 12 independent genes from the DNA of *M. massiliense* and *M. abscessus* clinical isolates, the template DNA (50 ng) and 20 pmol of each primer were added into a PCR mixture tube (AccuPower PCR PreMix; Bioneer, Daejeon, South Korea) containing one unit of Taq DNA polymerase, 250 μM of deoxynucleotide triphosphate, 10 mM Tris--HCl (pH 8.3), 10 mM KCl, 1.5 mM MgCl~2~, and gel loading dye. The final volume was adjusted to 20 μl with distilled water, and the reaction mixture was then amplified as follows: denaturation at 95°C (5 min); 30 cycles of denaturation at 95°C (30 sec), annealing at 62°C (30 sec), elongation at 72°C (45 sec), and final elongation at 72°C (5 min) -- using a model 9700 Thermocycler (Perkin-Elmer Cetus). Also, as a negative control, distilled water was amplified using all the primer sets. After amplification, the mixtures were electrophoresed in 1.5% agarose gel with GeneRuler™ 100 bp DNA ladder marker (Thermo Scientific, Pittsburgh, PA, United States).

Availability of supporting data
-------------------------------
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List of primers used in this study.
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###### Additional file 3

**Confirmation the deleted GPL biosynthesis related genes by PCR among clinical isolated*M. massiliense*and*M. abscessus.*** M, 100 bp DNA ladder; Lane 1, *M. massiliense* Type I Asan 51843; Lane 2, *M. massiliense* Type I Asan 50375; Lane 3, *M. massiliense* Type I Asan 15; Lane 4, *M. massiliense* Type II Asan 50594; Lane 5, *M. massiliense* Type II Asan 52012; Lane 6, *M. massiliense* Type II Asan 1; Lane 7, *M. massiliense* Type I (rough) Asan 22; Lane 8, *M. massiliense* Type I (rough) Asan 23; Lane 9, *M. massiliense* Type I (rough) Asan. 54790; Lane 10, *M. abscessus* (smooth) Asan 57214; Lane 11, *M. abscessus* (smooth) Asan 57388; Lane 12, *M. abscessus* (smooth) Asan 58417; Lane 13, *M. abscessus* (rough) Asan 55088; Lane 14, *M. abscessus* (rough) Asan 56232; Lane 15, *M. abscessus* (rough)Asan 56544; N, negative control.
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